Evidence map›Paper›PMID 40486890›Full record

ArticleFrontiers in psychology2025

Reliability and validity of the Chinese version of the Family Resilience Inventory.

Xiaobing Xu, Yan Wang, Juntong Meng, Wanlu Cao, Ye Liu

Abstract read
In one paragraph

Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaobing Xu *School of Nursing, Qingdao University, Qingdao, China.
Yan Wang *Qilu Hospital, Shandong University (Qingdao), Qingdao, China.
Juntong MengSchool of Nursing and Rehabilitation, Shandong University, Jinan, China.
Wanlu CaoSchool of Nursing, Qingdao University, Qingdao, China.
Ye LiuQilu Hospital, Shandong University (Qingdao), Qingdao, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Family resilience plays a crucial role in helping patients with chronic diseases manage their conditions and maintain overall well-being. The Family Resilience Inventory (FRI) assesses resilience across generations with a focus on protective and promotive factors. However, the FRI has not been translated into Chinese or validated for use among families managing chronic diseases. Therefore, this study aims to test assess the reliability and validity of the Chinese Version of the Family Resilience Inventory (FRI-C) among patients with chronic diseases. Methods: The Chinese version of the FRI was obtained through standardized forward translation and cultural adaptation. We recruited 307 patients with chronic diseases from a tertiary hospital in Qingdao, Shandong Province, to complete the FRI. Reliability was assessed using calculating Cronbach's alpha and Guttman split-half reliability. Construct validity was evaluated through the correlation of the FRI-C with the shortened Chinese version of the Family Resilience Assessment Scale (FRAS-C). Confirmatory factor analysis (CFA) was used to validate the structural and discriminant validity of the questionnaire. Results: The FRI-C had a Cronbach's alpha coefficient of 0.964 with 0.959 and 0.952 for the two factors. The split-half reliability was 0.716 for the total scale and 0.961 and 0.943 for the two factors. The FRI-C scales and factor scores were significantly correlated with the FRAS-C total score (r values between 0.692 and 0.810, Conclusion: The FRI-C demonstrated strong reliability and validity among patients with chronic diseases and it can be used to evaluate family resilience.

Indexed as

chronic diseasefamily resilienceinventoryreliabilityvalidity

Identifiers

PMID40486890
PMCPMC12142059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.